Navigation Links
Efficacy of acupressure to relieve migraine nausea presented at International Headache Congress
Date:6/26/2013

Boston, MA, June 26, 2013 Nausea is one of the most debilitating symptoms of migraine and affects 80 percent of migraine suffers in the United States. Leading headache physician, Dr. Zoltan Medgyessy of the Berolina Clinic in Lohne, Germany demonstrated in a trial that pressure to the P6 antiemetic point on the inner wrist with an acupressure wristband is an effective and quick therapy for relieving nausea of migraine sufferers. He will be presenting his findings to the U.S. for the first time at the International Headache Congress in Boston, MA on June 27 30, 2013.

Migraine can be a disabling neurological disorder. It affects 36 million Americans, according to the American Migraine Foundation, and is considered by the World Health Organization as the 19th leading cause of all years lived with disability for both males and females.

Dr. Medgyessy's acupressure study with the Department of Headache / Department of Psychosomatic at the Berolina Clinic included 41 patients who experienced an average of 33.1 migraine days during the previous three months with an average nausea intensity of 6.2 out of 10. Patients were given Sea-Band acupressure wristbands instead of antiemetic drugs during a migraine attack and 83 percent of patients noticed reduction of nausea. Reported nausea after therapy was rated a 2.9 out of 10 and relief was reported after an average of 28 minutes. Nearly all participants (98 percent) said they would use Sea-Band again for migraine nausea.

"Acupressure wristbands are drug-free and that is an important advantage in using this therapy for migraine nausea as they have no risks for interaction with migraine drugs or the side effects commonly experienced with antiemetics, such as dizziness or tiredness," commented Dr. Medgyessy. "There are still many unknowns about migraine, making findings such as these an important stride toward improving the quality of life for those who suffer from the condition. I'm grateful that the International Headache Congress has given me a platform to share the results of my team's study and look forward to discussing it with my colleagues."


'/>"/>

Contact: Stephanie LaDue
sladue@rlapr.com
914-241-0086
Robin Leedy & Associates, Inc.
Source:Eurekalert

Related biology news :

1. Rotavirus vaccine developed in India demonstrates strong efficacy
2. Protein improves efficacy of tumor-killing enzyme
3. BUSM researchers identify novel approach to study COPD and treatment efficacy
4. Discovery could increase efficacy of promising cystic fibrosis drug
5. Published clinical trial demonstrates efficacy of Sea-Band® for migraine-related nausea
6. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
7. Wake Forest Baptist Offers Tips on How to Avoid and Relieve Campaign Season Stress
8. PuraMed BioScience®, Inc., Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver, CO Region to Coincide with the NACDSs Marketplace 2012 Trade Convention
9. Getting to grips with migraine
10. All in the family: A genetic link between epilepsy and migraine
11. Technology eases migraine pain in the deep brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: